FDA Poised to Decide on First mRNA Flu Vaccine

The U.S. Food and Drug Administration (FDA) is expected to make a decision today regarding the approval of Moderna's mRNA-1010, the first messenger RNA (mRNA) vaccine for seasonal influenza. This potential approval could expand flu vaccine options, particularly for older adults, and pave the way for future combination vaccines.